Emami (531162) Aperçu de l'action
Emami Limited fabrique et commercialise des produits de soins personnels et de santé en Inde et dans le monde entier. Plus de détails
| Score flocon de neige | |
|---|---|
| Évaluation | 3/6 |
| Croissance future | 2/6 |
| Performances passées | 3/6 |
| Santé financière | 6/6 |
| Dividendes | 6/6 |
Récompenses
Analyse des risques
Aucun risque n'a été détecté pour 531162 à partir de nos contrôles de risques.
531162 Community Fair Values
Create NarrativeSee what 7 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Emami Limited Concurrents
Historique des prix et performances
| Historique des cours de bourse | |
|---|---|
| Prix actuel de l'action | ₹400.55 |
| Plus haut sur 52 semaines | ₹634.65 |
| Plus bas sur 52 semaines | ₹385.35 |
| Bêta | 0.22 |
| Variation sur 1 mois | -13.15% |
| Variation sur 3 mois | -15.58% |
| Variation sur 1 an | -30.81% |
| Variation sur 3 ans | 2.18% |
| Variation sur 5 ans | -24.09% |
| Évolution depuis l'introduction en bourse | 17,005.36% |
Nouvelles et mises à jour récentes
531162: Upcoming May Results And Board Decisions Will Support Bullish Outlook
Analysts have trimmed their fair value estimate for Emami from ₹800 to about ₹745, citing updated assumptions that include slightly higher revenue growth expectations, along with a lower projected profit margin and a reduced future P/E multiple. What's in the News Board meeting scheduled for May 21, 2026, at 12:00 Indian Standard Time to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026 (company filing).531162: Upcoming Results And Higher Board Meeting Focus Will Support Bullish Outlook
Analysts have raised their price target on Emami from ₹775.37 to ₹800.00, reflecting updated assumptions around discount rates, revenue growth, profit margins, and future P/E multiples. What's in the News Emami has scheduled a board meeting for May 21, 2026.
531162: Interim Dividend Will Be Insufficient To Offset Rich Future P/E
Analysts have cut their price target on Emami from about ₹453 to ₹425, reflecting updated assumptions for slightly higher revenue growth, a marginally higher discount rate, and a lower future P/E multiple. What's in the News Board meeting scheduled for May 21, 2026, to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026 (company filing).Recent updates
531162: Upcoming May Results And Board Decisions Will Support Bullish Outlook
Analysts have trimmed their fair value estimate for Emami from ₹800 to about ₹745, citing updated assumptions that include slightly higher revenue growth expectations, along with a lower projected profit margin and a reduced future P/E multiple. What's in the News Board meeting scheduled for May 21, 2026, at 12:00 Indian Standard Time to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026 (company filing).531162: Upcoming Results And Higher Board Meeting Focus Will Support Bullish Outlook
Analysts have raised their price target on Emami from ₹775.37 to ₹800.00, reflecting updated assumptions around discount rates, revenue growth, profit margins, and future P/E multiples. What's in the News Emami has scheduled a board meeting for May 21, 2026.531162: Interim Dividend Will Be Insufficient To Offset Rich Future P/E
Analysts have cut their price target on Emami from about ₹453 to ₹425, reflecting updated assumptions for slightly higher revenue growth, a marginally higher discount rate, and a lower future P/E multiple. What's in the News Board meeting scheduled for May 21, 2026, to consider and approve audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026 (company filing).531162: Interim Dividend And Revised Assumptions Will Support A Balanced Outlook
Analysts have trimmed their price target on Emami from ₹510 to about ₹453, pointing to updated assumptions around a lower future P/E multiple, an adjusted discount rate, and revised expectations for revenue growth and profit margins. What's in the News The board of directors declared a 2nd interim dividend of ₹6 per equity share of face value ₹1 each, described as 600% on 436,500,000 equity shares for the financial year 2025-26 (Key Developments).531162: Second Interim Dividend Will Support Bullish Long Term Outlook
Analysts have trimmed their price target on Emami by about ₹31 to reflect updated assumptions around fair value, discount rate, revenue growth, profit margin, and future P/E expectations. What's in the News The board approved a second interim dividend of ₹6 per equity share of ₹1 each, equal to 600% on 436,500,000 equity shares for FY 2025-26, with the record date set for 10 February 2026 and payment scheduled on or before 6 March 2026 (Key Developments).
531162: February Dividend And Board Review Will Support Bullish Outlook
Analysts have trimmed their fair value estimate for Emami to ₹637 from ₹651, citing slightly adjusted assumptions on discount rate, revenue growth, profit margin and future P/E that point to a marginally more conservative outlook on the stock's valuation. What's in the News A board meeting on 4 February 2026 to review unaudited standalone and consolidated financial results for the quarter ended 31 December 2025 and to consider a 2nd interim dividend for FY 2025-26 (company filing).531162: Interim Dividend And Stable Assumptions Will Support A Balanced Outlook
Analysts have maintained their fair value estimate for Emami at ₹510. They have made only minor adjustments to assumptions such as discount rate, revenue growth, profit margin and future P/E, which feed into the updated price target rationale.531162: Board Review And Interim Dividend Will Shape A Balanced Outlook
Analysts have trimmed their price target for Emami from ₹540.54 to ₹510.00, citing refreshed assumptions that include slight adjustments to revenue growth, profit margins and the future P/E multiple under a marginally lower discount rate. What's in the News Emami has scheduled a board meeting on Feb 04, 2026 to review unaudited standalone and consolidated financial results for the quarter ended 31 December, 2025 (Key Developments).531162: February Board Meeting And Dividend Decision Will Reinforce Bullish Outlook
Analysts have trimmed their price target for Emami slightly to ₹651 from about ₹653. The adjustment reflects small tweaks to their fair value, discount rate, revenue growth and profit margin assumptions, alongside a marginally lower expected future P/E multiple.531162: February Dividend Decision Will Support Bullish Long-Term View
Analysts have made only a minor adjustment to their price view on Emami, with the updated fair value at ₹653.25. A slightly lower discount rate, along with revised assumptions for revenue growth, profit margin, and future P/E, serve to fine tune rather than overhaul the prior framework.531162: Upcoming Dividend Decision Will Support Bullish Long Term Outlook
Analysts have trimmed their price target on Emami from ₹883 to ₹807. This reflects slightly lower margin and valuation expectations that more than offset modestly stronger projected revenue growth and a reduced discount rate.531162: Interim Dividend Decision At November Meeting Will Support Bullish Outlook
Analysts have nudged their price target on Emami slightly higher to align with a fair value of ₹653.25. This reflects marginally lower perceived risk and a steady outlook on growth, margins, and future valuation multiples.531162: Board Will Consider Interim Dividend At November 10 Results Meeting
Analysts have revised their price target for Emami down from ₹697.96 to ₹653.25. They cite updated assessments of the company's growth prospects and valuation metrics as reasons for the change.531162: Board To Weigh Interim Dividend At November 10 Meeting
Analysts have slightly revised their price target for Emami downward from ₹706.24 to ₹697.96. This change reflects minor adjustments in growth and profitability expectations.
Relaunching Fair And Handsome And Capitalizing On Dermicool Innovations Will Propel Earnings Growth
Strategic relaunches and product innovations aim to boost revenue, particularly in Fair and Handsome, Kesh King, Dermicool, and BoroPlus Soft segments.Rendement pour les actionnaires
| 531162 | IN Personal Products | IN Marché | |
|---|---|---|---|
| 7D | -6.6% | 0.1% | 2.1% |
| 1Y | -30.8% | -8.3% | 0.8% |
Rendement vs Industrie: 531162 a sous-performé le secteur Indian Personal Products qui a rapporté -8.3 % au cours de l'année écoulée.
Rendement vs marché: 531162 a sous-performé le marché Indian qui a rapporté 0.8 % au cours de l'année écoulée.
Volatilité des prix
| 531162 volatility | |
|---|---|
| 531162 Average Weekly Movement | 4.5% |
| Personal Products Industry Average Movement | 5.5% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in IN Market | 10.3% |
| 10% least volatile stocks in IN Market | 4.8% |
Cours de l'action stable: 531162 n'a pas connu de volatilité de prix significative au cours des 3 derniers mois par rapport au marché Indian.
Volatilité au fil du temps: La volatilité hebdomadaire de 531162 ( 4% ) est restée stable au cours de l'année écoulée.
À propos de l'entreprise
| Fondée | Salariés | PDG | Site web |
|---|---|---|---|
| 1974 | 3,217 | Harsha Agarwal | www.emamiltd.in |
Emami Limited fabrique et commercialise des produits personnels et de santé en Inde et dans le monde entier. Elle propose des crèmes antiseptiques ayurvédiques, de la poudre de chaleur épineuse, de la lotion corporelle doodh kesar, de la lotion aloe neem, de la vasocarine, de l'huile de coco, du gel d'aloe vera et des produits d'hygiène sous la marque Boroplus ; cool oil, extra thanda, gold ayurvedic oil, therapy ayurvedic body massage and stress relief oil, maxx cool talc, and cool talc sous la marque Navratna ; et balm, balm ultra-power, quick relief roll-on, ortho vedic oil, ointment, relief gel and spray, healthcare products, pancharishta, nityam, and kesari jivan sous la marque Zandu. L'entreprise propose également une crème éclatante et un nettoyant facial éclatant instantané pour hommes sous la marque Fair and Handsome ; des produits de soins capillaires et des shampooings sous la marque Kesh King ; un baume sous la marque Mentho Plus ; de la poudre contre la chaleur épineuse sous la marque Dermicool ; de l'huile capillaire, des shampooings et des revitalisants sous la marque Emami 7 Oils in One ; des désodorisants sous la marque HE ; les colorations capillaires sous la marque Emami Diamond Shine ; le talc sous la marque Emami Golden Beauty ; la crème de beauté à base de plantes sous la marque Emami Naturally Fair ; le dentifrice sous la marque Ayucare ; les colorations et huiles capillaires sous la marque Emami Gold ; et les crèmes hydratantes, lotions, crèmes douces, crèmes et huiles à base de glycérine, gelée de pétrole, shampooings pour bébés et autres produits pour la peau sous la marque Cream21.
Emami Limited Résumé des fondamentaux
| 531162 statistiques fondamentales | |
|---|---|
| Capitalisation boursière | ₹174.84b |
| Bénéfices(TTM) | ₹7.75b |
| Recettes(TTM) | ₹37.80b |
Le site 531162 est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
| 531162 compte de résultat (TTM) | |
|---|---|
| Recettes | ₹37.80b |
| Coût des recettes | ₹11.38b |
| Marge brute | ₹26.42b |
| Autres dépenses | ₹18.66b |
| Les revenus | ₹7.75b |
Derniers bénéfices déclarés
Mar 31, 2026
Prochaine date de publication des résultats
s/o
| Résultat par action (EPS) | 17.76 |
| Marge brute | 69.89% |
| Marge bénéficiaire nette | 20.51% |
| Ratio dettes/capitaux propres | 4.2% |
Quelles ont été les performances à long terme de 531162?
Voir les performances historiques et les comparaisonsDividendes
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/27 18:47 |
| Cours de l'action en fin de journée | 2026/05/27 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2026/03/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Emami Limited est couverte par 43 analystes. 20 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Parin Tanna | 360 ONE Capital Market Private Limited |
| null null | Anand Rathi Shares and Stock Brokers Limited |
| Ajay Thakur | Anand Rathi Shares and Stock Brokers Limited |